Accelerating HCP engagement in Singapore using customer reference data
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

24

Sep 2021

Amnio Technology Awarded U.S. Patent for Amniotic Allografts

Amnio Technology LLC a global leader in the development and distribution of amniotic tissue allografts is announcing today that the United States Patent and Trademark Office has issued a new patent titled Enriched Multilayer Amnion Derived Tissue Graft The new patent strengthens Amnio Technologys in...

24

Sep 2021

Phenomenex Announces the Release of New Biozen® SEC Size Exclusion Chromatography Columns

Phenomenex Inc a global leader in the research and manufacture of advanced technologies for the separation sciences announces the successful launch of NEW Biozen SEC Size Exclusion Chromatography Columns to the existing Biozen portfolio of biological workflow products for the analysis of monoclonal...

23

Sep 2021

Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine Booster

Pfizer Inc and BioNTech SE announced that the US Food and Drug Administration FDA has authorized for emergency use a booster dose of the PfizerBioNTech COVID Vaccine for individuals years of age and older individuals through years of age at high risk of severe COVID and individuals through year...

23

Sep 2021

AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies

AbCellera and Everest Medicines Limited announced that they have entered into a multiyear collaboration and license agreement to discover therapeutic antibodies for up to targets selected by Everest The partnership will help to expand Everests portfolio of novel medicines across multiple indication...

press releasesRead more...

24

Sep 2021

Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asia announced today that the Center for Drug Evaluation CDE of the National Medical Products Administration NMPA o...

23

Sep 2021

AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity

AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery development and commercialisastion of the proprietary selfamplifying RNA saRNA therapeutics platform developed at Imperial College London The strategic longterm research collaboration aims to optimise and validate V...

23

Sep 2021

Tonix Pharmaceuticals Expands Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics

Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company today announced it has expanded its research collaboration with Columbia University The research collaboration is focused on studying immune responses to COVID in healthy volunteers who have recovered from COVID or were asy...

23

Sep 2021

Quell Therapeutics Significantly Expands Clinical Manufacturing Capacity for its Engineered Treg Cell Therapies through a Collaboration with the Cell and Gene Therapy Catapult

Quell Therapeutics Ltd Quell the world leader in developing engineered Tregulatory Treg cell therapies for serious medical conditions driven by the immune system today announced it has entered a collaboration with the Cell and Gene Therapy Catapult CGT Catapult The collaboration will expand Quells c...

EventsRead more...

27 - 28

Sep 2021

27 - 28

Sep 2021

29 - 30

Sep 2021

TOP ARTICLES

  • 2

    Artificial Intelligence

    Artificial Intelligence AI is a field of computer science that studies how machines imitate the intelligence o...
  • 3

    Homeopathic Science

    Homeopathy a controversial medical system discovered by a German physician Samuel Hahnemann was first postula...

KNOWLEDGE BANK

  • Interviews

    Sebastian Kleebank

    Knowledge Gain Through High Parallel Bioprocess Setups

    Product Life Cycle Manager, Eppendorf AG

    Sebastian Kleebank studied Bioengineering at the University of Applied Sciences in Juelich followed by his PhD at the RWTH Aachen Institute for Molecular Biotechnology In his actual position as a Product Life Cycle Manager at Eppendorf AG Business Unit Bioprocess he is responsible for the smallscale product portfolio During his years in the bioprocess industry he gained a lot of experience in sma...
  • Articles

    A Structured Review on BCRP-Mediated Multidrug Resistance

    Many of the human ABC proteins are efflux transporters and three of them namely Pglycoprotein Pgp gene symbol ABCB the multidrug resistance protein MRP gene symbol ABCC and the breast cancer resistance protein BCRP gene symbol ABCG have been implicated to be the major efflux transporters responsible for multidrug resistance in cancer cells

  • Techno Trends

    Millipore\'s innovative MobiusT Disposable TFF Assemblies

    Millipore Corporation has announced the availability of new Mobius disposable TFF assemblies which offer flexible selfcontained solutions that reduce validation efforts increase process speed and mitigate risks Mobius disposable TFT assemblies are being showcased at IBC Disposables for Biopharmaceutical Manufacturing conference California Millipore employs appr

  • White Papers

    Crippled by Cost? CMO Quo Vadis

    Introduction The global CMO market is said to reach USD billion by Patent expiry of drugs stringent price regulations especially in Europe US to purchase drugs from pharma companies Government budget cuts for pharma RD these are the forces which are expected to reshape the future of pharma and the CMO industry At least manufacturing facilities owned by pharma companies were shut dow

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...